push health semaglutide price The for Medicare to cover weight-loss drugs: An explainer BREAKING: The FDA has approved

Table of Contents Why Ozempic Can Cause Nausea and Vomiting Ozempic (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK for the treatment of type 2 diabetes mellitus

However, phentermine carries its own risks and is typically only approved for short-term use, making direct comparison complicated

It's important to note that semaglutide is not recommended for patients with severe gastrointestinal disease, including severe gastroparesis, as these conditions have not been studied in clinical trials and may be exacerbated by the medication's effects on gastric emptying

The decision to continue, adjust, or stop Ozempic should be made collaboratively with your healthcare provider, taking into account the severity of symptoms, their impact on your quality of life, and the therapeutic benefits you are receiving